Where Will Eli Lilly Be in 5 Years?
What a difference five years can make. Just look at Eli Lilly (NYSE: LLY). In April 2020, the drugmaker stood in the shadows to some extent with companies including Johnson Johnson, , and Merck boasting larger market caps. Today, Lilly ranks as not only the biggest pharmaceutical company on the planet but also the biggest healthcare company in the world with a market cap of roughly $718 billion.
But what matters more than Lilly's accomplishments in the past is what the company could do in the future. Where will Eli Lilly be in five years?
Despite Lilly's huge success in treating diabetes and obesity, it's not the leader in those markets. That honor belongs to Novo Nordisk (NYSE: NVO), which sells the blockbuster drugs Ozempic and Wegovy for treating diabetes and obesity, respectively. However, I predict that Lilly will be the top dog in diabetes and obesity within the next five years.
Source Fool.com
Pfizer Inc. Aktie
Positive Tendenz bei Pfizer Inc. mit mehreren Buy-Einschätzungen als Sell-Einschätzungen.
Ein Kursziel von 27 € für Pfizer Inc. könnte zu einer Steigerung von mehr als 20% gegenüber dem aktuellen Kurs von 21.36 € führen.
